North America Diabetes Care Devices Market Share

Statistics for the 2023 & 2024 North America Diabetes Care Devices market share, created by Mordor Intelligence™ Industry Reports. North America Diabetes Care Devices share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Diabetes Care Devices Industry

A select few big players control the market. Abbott's new FreeStyle Libre Flash glucose monitoring system was approved, which is the first continuous blood sugar monitor for people with diabetes that does not need backup finger prick tests. Innovations in test strips are increasing and are under development. For example, the new test strip includes features such as underfill detection and provides the user with the ability to reapply blood when the test strip is underfilled ("second chance" sampling). Dexcom acquired TypeZero Technologies, paving the way for automated insulin delivery. The acquisition has sent Dexcom ahead in the race to create an artificial pancreas system rather than simply offering a continuous glucose monitoring device.

North America Diabetes Care Devices Market Leaders

  1. Dexcom

  2. Medtronic

  3. F. Hoffmann-La Roche AG

  4. Novo Nordisk

  5. Becton, Dickinson and Company

*Disclaimer: Major Players sorted in no particular order

North America Diabetes Care Devices Market Concentration

North America Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)